Key Takeaways & Executive Findings
- •• Single-cell RNA sequencing identified 23 distinct immune cell clusters in periodontitis, revealing the heterogeneity of the immune microenvironment. • Mendelian randomization analysis established causal relationships between three key genes (ANXA1, SLC11A1, VIM) and periodontitis risk. • Pathway enrichment and immune infiltration analyses indicated that these genes are involved in critical immune regulatory mechanisms. • Experimental validation confirmed upregulation of ANXA1, SLC11A1, and VIM in periodontitis tissues, suggesting their potential as therapeutic targets.
Abstract
BACKGROUND: Periodontitis is a chronic inflammatory disease. Previous research has predominantly focused on specific immune cells or cytokines. Therefore, systematically elucidating its immune mechanisms and discovering novel therapeutic targets hold significant implications. OBJECTIVE: To analyze the expression profiles of periodontitis-associated immune cell subpopulations and identify key differentially expressed genes with a causal relationship to the disease, thereby exploring potential molecular mechanisms and key genes involved in periodontitis and immune cell dynamics. METHODS: Single-cell RNA sequencing data from the GEO database were used to analyze immune cell subset heterogeneity and identify differentially expressed genes. Mendelian randomization analysis was performed using expression quantitative trait loci data to infer causal relationships between immune cell gene expression and periodontitis risk. Pathway enrichment and immune infiltration analyses were performed on the identified causal genes to reveal the associations between differentially expressed genes and immune cells with the development and progression of periodontitis. CellChat trajectory analysis was used to explore intercellular communication. To validate key findings, gingival tissue samples were collected from 20 patients with periodontitis diagnosed by the Department of Stomatology at The First Affiliated Hospital of Shihezi University (periodontitis group) and 20 healthy gingival tissue samples from patients undergoing orthodontic or impacted tooth extraction (control group). RT-qPCR and immunohistochemistry were used to detect the expression of key genes. RESULTS AND CONCLUSION: Comprehensive analysis identified 23 immune cell clusters in periodontitis and three key genes with significant causal relationships to periodontitis risk: annexin A1 (ANXA1), solute carrier family 11 member 1 (SLC11A1), and vimentin (VIM). Pathway enrichment analysis revealed their involvement in key immune regulatory mechanisms. Further analyses of immune subtype receptor-ligand interactions and key cell subtype trajectories characterized the distinct roles of ANXA1, SLC11A1, and VIM in disease progression. Compared with healthy controls, the mRNA expression levels of ANXA1, SLC11A1, and VIM were upregulated in periodontitis tissues (P < 0.05). This study reveals the key roles of immune cell subpopulations in periodontitis and validates causal genes (ANXA1, SLC11A1, VIM) associated with the disease.
1. Introduction
Periodontal disease is a chronic, non-specific, infectious, and complex inflammatory disease [1]. Activated immune cells, particularly T cells and B cells, are considered key factors in the progression of periodontitis [2-3]. Studies have shown that the role of immune cells is crucial for developing effective prevention and treatment strategies for periodontitis [4]. The development of periodontitis is influenced by multiple factors, including genetics, environmental conditions, microbial infection, and lifestyle. Despite significant advances in periodontitis research, the specific etiology and pathogenesis at the molecular level remain incompletely understood.
Single-cell RNA sequencing plays a vital role in revealing molecular mechanisms and identifying target cells, as it can uncover heterogeneity among cells and the complexity of gene expression regulation [5]. Previous studies have shown that differentially expressed genes in monocytes are associated with periodontitis [6]. However, these results rarely reflect the combination of immune cells and key genes. Mendelian randomization analysis can utilize genetic variants as tools in a 'natural random experiment' to test causality. This approach enables classification and characterization of each cell at single-cell resolution, thereby uncovering biological pathways related to transcriptomic features and phenotypic outcomes [7].
By combining Mendelian randomization with bioinformatics analysis, new perspectives can be brought to related research [8]. This study integrates multiple datasets, including single-cell RNA sequencing data and expression quantitative trait loci data, to explore the correlation and causal association between key genes and immune cells in periodontitis by combining single-cell sequencing and Mendelian randomization. Through single-cell sequencing, immune cell-related diagnostic features and clusters in periodontitis are identified, and Mendelian randomization is further used to screen genetic variants associated with the onset and progression of periodontitis, enhancing the precision of disease cell-specific mechanism research. Validation is performed via RT-qPCR and immunohistochemistry, providing a new approach for the diagnosis and treatment of periodontitis and offering new insights for personalized therapy.
Loading authentic research manuscript (Pages 1–5)...
Qiu Xuedi, Guo Chao, He Jiayue, Zhou Zheng (2026). Single-cell sequencing data identifies differentially expressed genes and immune cell subtypes in periodontitis patients. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21345
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the main objective of this study?
The main objective is to analyze the expression profiles of periodontitis-associated immune cell subpopulations and identify key differentially expressed genes with a causal relationship to the disease, thereby exploring potential molecular mechanisms and key genes involved in periodontitis and immune cell dynamics.
What methods were used in this research?
The study utilized single-cell RNA sequencing data from the GEO database to analyze immune cell heterogeneity and identify differentially expressed genes. Mendelian randomization analysis was performed using eQTL data to infer causal relationships. Pathway enrichment, immune infiltration, and CellChat trajectory analyses were conducted. Validation was performed using RT-qPCR and immunohistochemistry on clinical samples.
What are the key findings of the study?
The study identified 23 immune cell clusters in periodontitis and three key genes (ANXA1, SLC11A1, VIM) with significant causal relationships to periodontitis risk. These genes were upregulated in periodontitis tissues and are involved in key immune regulatory mechanisms.
How were the key genes validated?
The key genes were validated by collecting gingival tissue samples from 20 periodontitis patients and 20 healthy controls. RT-qPCR and immunohistochemistry confirmed that ANXA1, SLC11A1, and VIM mRNA expression levels were significantly upregulated in periodontitis tissues compared to healthy controls (P < 0.05).
What is the significance of this research?
This research provides a comprehensive understanding of the immune cell dynamics in periodontitis and identifies potential therapeutic targets. By combining single-cell sequencing and Mendelian randomization, it offers a novel approach for studying disease mechanisms and may contribute to personalized treatment strategies for periodontitis.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.